Eastern Cooperative Oncology Group
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://ecog-acrin.org
Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim
- Conditions
- First Posted Date
- 2011-07-06
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 48
- Registration Number
- NCT01388569
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
- Conditions
- First Posted Date
- 2011-06-29
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 220
- Registration Number
- NCT01385150
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-11-17
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 390
- Registration Number
- NCT01242800
- Locations
- 🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸Resurrection Medical Center, Chicago, Illinois, United States
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
- Conditions
- First Posted Date
- 2010-06-25
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 559
- Registration Number
- NCT01150643
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
- Conditions
- First Posted Date
- 2010-06-16
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 225
- Registration Number
- NCT01145469
Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 90
- Registration Number
- NCT01084083
- Locations
- 🇺🇸
Northwest Ohio Oncology Center, Maumee, Ohio, United States
🇺🇸McKee Medical Center, Loveland, Colorado, United States
🇺🇸Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2023-06-28
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 136
- Registration Number
- NCT01079780
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸Hematology and Oncology Associates, Chicago, Illinois, United States
🇺🇸John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
- Conditions
- Interventions
- First Posted Date
- 2009-09-17
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 540
- Registration Number
- NCT00978458
- Locations
- 🇺🇸
University of Illinois Cancer Center, Chicago, Illinois, United States
🇺🇸Illinois CancerCare - Eureka, Eureka, Illinois, United States
🇺🇸Evanston Hospital, Evanston, Illinois, United States
Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100
- Conditions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 500
- Registration Number
- NCT00899418
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 1873
- Registration Number
- NCT00897767
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
🇺🇸Tufts Medical Center Cancer Center, Boston, Massachusetts, United States